Literature DB >> 3772816

Factors affecting the pressure-distributing properties of foam mattress overlays.

T A Krouskop, P S Noble, J Brown, R Marburger.   

Abstract

A universal concern of those in nursing care is the occurrence of decubitus ulcers. To minimize this problem foam overlays are routinely used on hospital beds throughout the country. This study was undertaken to develop laboratory testing procedures which will reliably predict the support characteristics of mattress overlays in clinical service. Initially, test methods based on constant load and constant deformation boundary conditions were developed. These methods were applied to measure the pressure-distributing properties of 10 polyurethane foams fabricated in a wide range of pliancies and densities. Based on these laboratory data, a single index was developed to express the effectiveness of each overlay in distributing interface pressures. This index was found to be influenced by the stiffness (ILD), density, and thickness of each device. These data were then compared with measurements of interface pressure obtained from volunteer subjects who were supported on mattress overlays fabricated from each of the original foams. Correlation of these data with the laboratory results demonstrated that the effectiveness index was an accurate predictor of mattress overlay performance under end-use conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772816

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  2 in total

1.  Prevention of deep tissue injury through muscle contractions induced by intermittent electrical stimulation after spinal cord injury in pigs.

Authors:  Leandro R Solis; Elizabeth Twist; Peter Seres; Richard B Thompson; Vivian K Mushahwar
Journal:  J Appl Physiol (1985)       Date:  2012-11-21

2.  Relationship between a pressure redistributing foam mattress and pressure injuries: An observational prospective cohort study.

Authors:  Dorothy Li Bai; Tsai-Wen Liu; Hsiu-Ling Chou; Yeh-Liang Hsu
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.